Annual Cash & Cash Equivalents
$35.41 M
-$34.65 M-49.45%
December 31, 2023
Summary
- As of February 6, 2025, CADL annual cash & cash equivalents is $35.41 million, with the most recent change of -$34.65 million (-49.45%) on December 31, 2023.
- During the last 3 years, CADL annual cash & cash equivalents has risen by +$360.00 thousand (+1.03%).
- CADL annual cash & cash equivalents is now -57.15% below its all-time high of $82.64 million, reached on December 31, 2021.
Performance
CADL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$16.56 M
-$4.90 M-22.82%
September 30, 2024
Summary
- As of February 6, 2025, CADL quarterly cash and cash equivalents is $16.56 million, with the most recent change of -$4.90 million (-22.82%) on September 30, 2024.
- Over the past year, CADL quarterly cash and cash equivalents has dropped by -$4.90 million (-22.82%).
- CADL quarterly cash and cash equivalents is now -82.45% below its all-time high of $94.32 million, reached on March 31, 2022.
Performance
CADL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CADL Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -49.5% | -22.8% |
| 3 y3 years | +1.0% | -76.4% |
| 5 y5 years | +583.8% | -76.4% |
CADL Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -57.1% | at low | -82.5% | at low |
| 5 y | 5-year | -57.1% | +583.8% | -82.5% | at low |
| alltime | all time | -57.1% | +583.8% | -82.5% | at low |
Candel Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $16.56 M(-22.8%) |
| Jun 2024 | - | $21.45 M(-16.6%) |
| Mar 2024 | - | $25.71 M(-27.4%) |
| Dec 2023 | $35.41 M(-49.5%) | $35.41 M(-17.6%) |
| Sep 2023 | - | $42.98 M(-17.2%) |
| Jun 2023 | - | $51.89 M(-12.4%) |
| Mar 2023 | - | $59.26 M(-15.4%) |
| Dec 2022 | $70.06 M | $70.06 M(-9.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $77.18 M(-11.1%) |
| Jun 2022 | - | $86.78 M(-8.0%) |
| Mar 2022 | - | $94.32 M(+14.1%) |
| Dec 2021 | $82.64 M(+135.8%) | $82.64 M(-6.5%) |
| Sep 2021 | - | $88.39 M(+263.5%) |
| Jun 2021 | - | $24.32 M(-16.6%) |
| Mar 2021 | - | $29.15 M(-16.8%) |
| Dec 2020 | $35.05 M(+576.8%) | $35.05 M |
| Dec 2019 | $5.18 M | - |
FAQ
- What is Candel Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Candel Therapeutics?
- What is Candel Therapeutics annual cash & cash equivalents year-on-year change?
- What is Candel Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Candel Therapeutics?
- What is Candel Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Candel Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of CADL is $35.41 M
What is the all time high annual cash & cash equivalents for Candel Therapeutics?
Candel Therapeutics all-time high annual cash & cash equivalents is $82.64 M
What is Candel Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, CADL annual cash & cash equivalents has changed by -$34.65 M (-49.45%)
What is Candel Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CADL is $16.56 M
What is the all time high quarterly cash and cash equivalents for Candel Therapeutics?
Candel Therapeutics all-time high quarterly cash and cash equivalents is $94.32 M
What is Candel Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, CADL quarterly cash and cash equivalents has changed by -$4.90 M (-22.82%)